1. Recht J, Ashley EA, White NJ: Safety of 8-Aminoquinoline Antimalarial Medicines. 2014, Geneva: World Health Organization, Downloadable at: http://www.who.int/malaria/publications/atoz/9789241506977/en/
2. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE: Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ. 1960, 22: 621-631.
3. Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, Cao J, Kachur SP, Feachem RG, Gosling RD, Gao Q: Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province. China Malar J. 2013, 12: 383-10.1186/1475-2875-12-383.
4. Kondrashin AV, Baranova AM, Ashley EA, Recht J, White NJ, Sergiev VM: Mass primaquine treatment to eliminate vivax malaria; lessons from the past. Malar J. 2014, 13: 51-10.1186/1475-2875-13-51.
5. Garfield RM, Vermund SH: Changes in malaria incidence after mass drug administration in Nicaragua. Lancet. 1983, 2: 500-503.